Literature DB >> 5576438

Reduction in venous thromboembolism by agents affecting platelet function.

E W Salzman, W H Harris, R W DeSanctis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576438     DOI: 10.1056/NEJM197106102842303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

1.  No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.

Authors:  Mhamad Faour; Nicolas S Piuzzi; David P Brigati; Alison K Klika; Michael A Mont; Wael K Barsoum; Carlos A Higuera
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

2.  Aspirin for reducing cancer metastases?

Authors:  U K Henschke; G J Luande; J D Choppala
Journal:  J Natl Med Assoc       Date:  1977-08       Impact factor: 1.798

3.  Prevention of pulmonary emboli in hospitalized patients.

Authors:  J C Hubbard
Journal:  Can Fam Physician       Date:  1983-02       Impact factor: 3.275

Review 4.  Thromboembolism. Diagnosis and treatment.

Authors: 
Journal:  West J Med       Date:  1974-03

Review 5.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

6.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

7.  Heparin prophylaxis for deep vein thrombosis and pulmonary embolism.

Authors:  C Olcott
Journal:  West J Med       Date:  1976-09

8.  [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1977-01-15

Review 9.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (furadantin).

Authors:  E C Rossi; N W Levin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.